Europe Syfovre Review Effectively Hits the Reset Button
⬆ $Apellis Pharmaceuticals(APLS)$ - Earlier today, Apellis announced the review clock for pegcetacoplan’s MAA in geographic atrophy (GA) has been reset to 180 days (here). This... Continue reading on Smartkarma:- https://www.smartkarma.com/insights/europe-syfovre-review-effectively-hits-the-reset-button?utm_source=tiger_community By CGS CIMB Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cgs-cimb-research?utm_source=tiger_community On Apellis Pharmaceuticals (APLS):- https://www.smartkarma.com/entities/apellis-pharmaceuticals-inc?utm_source=tiger_community
Apellis Pharmaceuticals Inc.: Initiation Of Coverage - A Dominant Force In PNH & Nephrology Mark...
⬆ $Apellis Pharmaceuticals(APLS)$ - Apellis Pharmaceuticals delivered decent financial results for the fourth quarter and full year of 2023. The company ended the year in a solid... Continue reading on Smartkarma:- https://www.smartkarma.com/insights/apellis-pharmaceuticals-inc-initiation-of-coverage-a-dominant-force-in-pnh-nephrology-market-major-drivers?utm_source=tiger_community By Baptista Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/baptista-research?utm_source=tiger_community On Apellis Pharmaceuticals (APLS):- https://www.smartkarma.com/entities/apellis-pharmaceuticals-inc?utm_source=tiger_community